People of PCI: Michael Yocum

Posted on September 27, 2019 — Jessica Jones Gupta

The Penn Center for Innovation is often the behind-the-scenes force promoting Penn discoveries, innovation, and technology. With this blog series, we’re moving the amazing PCI staff into the spotlight to learn about what they do, what led them to PCI, and how their work helps the greater Penn community. Our third spotlight shines on Michael…

Linnaeus Therapeutics announces FDA clearance of investigational new drug application for LNS8801

Posted on September 24, 2019 — Jessica Jones Gupta

Linnaeus Therapeutics, Inc., a privately held, clinical-stage biopharmaceutical company focused on the development and commercialization of novel, small molecule oncology therapeutics, announced that the U.S. Food and Drug Administration (FDA) has cleared the company’s investigational new drug application (IND) for LNS8801, a small molecule agonist of the G protein-coupled estrogen receptor (GPER). Linnaeus is developing…

Turning the Tide: Fast fentanyl testing can save lives

Posted on September 23, 2019 — Jessica Jones Gupta

For the first responders treating a possible opioid overdose, it is vitally important to quickly identify the drug the patient took. A dosage of naloxone administered immediately to someone overdosing on fentanyl can bring them back from the brink and prevent long-term damage. Unfortunately, the recent influx of illegal fentanyl and fentanyl-laced drugs, means that…

PACT Capital Conference 2019

Posted on — Jessica Jones Gupta

The Philadelphia Alliance for Capital and Technologies (PACT) Conference is Thursday, September 26, 2019 at XFINITY Live! PACT will offer a full day of content, speakers, networking and company pitches. Each year, the PACT Capital Conference connects the region’s best and brightest entrepreneurs to investors. It showcases mature companies from the Philadelphia region along with…

Penn biopharma spinout closes $12M financing

Posted on September 20, 2019 — Jessica Jones Gupta

Linnaeus Therapeutics is a development stage biotech company engaged in the identification and development of small molecule agents for the treatment of cancer. Read more. (Philadelphia Business Journal)

What’s hot with VC investors: Lessons from the commercialization speaker series with Barbara Schilberg

Posted on September 19, 2019 — Jessica Jones Gupta

PCI and Penn Medicine were pleased to have Barbara Schilberg of BioAdvance kick off the 2019 fall lunchtime speaker series.  Barbara has more than 30 years of experience working with academic technologies and start-up companies in the life sciences sector.   Her topic, What’s Hot with VC Investors, attracted one of the largest audiences to…

OVPR opened its doors to the Penn community

Posted on — Jessica Jones Gupta

On Tuesday, September 17, 2019, the Office of the Vice Provost for Research celebrated its new offices at 3600 Civic Center Blvd. by opening its doors to the Penn community and partners. The first annual Navigating Commercialization @ Penn Open House was a huge success, with 110 attendees from all Penn schools and major partners….

The redemption of James Wilson, gene therapy pioneer

Posted on September 13, 2019 — Jessica Jones Gupta

A deep look into the history of gene therapy through the work of Penn’s Dr. James Wilson. Read more. (Chemical & Engineering News)

Philly’s Mini Maker Faire for local inventors and crafters returns this October

Posted on September 9, 2019 — Jessica Jones Gupta

Despite the national organization shutting down earlier this year, the Philly chapter of the Maker Faire will return to Pennovation next month — and hopes to double attendance. Read More. (Technical.ly Philly)

Alzheimer’s pioneer Virginia Lee wins $3 million Breakthrough Prize for work at Penn

Posted on September 5, 2019 — Jessica Jones Gupta

Virginia Lee, director of the Center for Neurodegenerative Disease Research at Penn’s Perelman School of Medicine, was awarded one of seven $3 million Breakthrough Prizes. Read More (Philadelphia Inquirer)